New York, Feb 27, 2026, 08:31 EST — Premarket.
- LMAT held steady before the bell, following a 24.4% surge Thursday that pushed shares to $113.69 at the close.
- LeMaitre reported Q4 revenue of $64.5 million and projected 2026 sales around $280 million at the midpoint.
- Citizens bumped its price target up to $118 after the company issued EPS guidance that topped consensus estimates.
LeMaitre Vascular barely budged ahead of the bell Friday, this after a 24.4% rally the day before. Shares wrapped Thursday at $113.69, briefly hitting $115.33 during the session. Volume jumped to nearly 1.27 million shares — up sharply from the prior day’s 203,000.
This kind of spike carries weight for a company often priced on subtle tweaks in growth and margins. After Thursday’s surge, the focus shifts—Friday becomes a test, with investors picking over whether the updated outlook holds water and can actually support shares staying up here.
LeMaitre logged fourth-quarter revenue of $64.5 million late Wednesday, marking a 16% gain over last year. Organic growth accounted for 15% of that, stripping out currency and one-offs. Diluted EPS jumped 39% to $0.68. Gross margin widened by 240 basis points, reaching 71.7%. For 2026, the company projects sales between $276 million and $284 million, with EPS in the $2.81 to $3.01 range. CEO George LeMaitre pointed to stronger international Artegraft demand and higher selling prices as key drivers for the quarter.
Daniel Stauder at Citizens bumped his price target on the shares up to $118 from $113, sticking with a Market Outperform rating, according to an Investing.com report. Stauder pointed out the company’s midpoint adjusted EPS guidance — around $2.91 — comes in about 13% higher than consensus forecasts, which hover near $2.58.
Traders will be eyeing one key detail: whether the stock stays above its old range once the regular session kicks off, or slips, pressured by a sharp one-day re-rate. The focus won’t end there. Estimate revisions in the coming days are crucial, since Thursday’s action hinged on forward guidance.
Still, there are bumps ahead. LeMaitre flagged a cyber incident from January during its earnings call and said the internal probe isn’t over yet, though key systems came back online with “minimal to no disruption.” Management cautioned that shifting RestoreFlow processing and bringing a new 34,000-square-foot warehouse online could squeeze margins later this year. Capital spending is also headed higher—management pegged 2026 outlays at roughly $11 million. Investing
Thursday’s rally narrows the margin for error—costs, pricing, or procedure volumes don’t have much wiggle room now. If margins hit a snag, the stock can drop quickly, and usually does.
Investors have some key dates ahead: the board bumped up the quarterly dividend by 25%, now at $0.25 per share, set for payment on March 26 to holders on record as of March 12. There’s also a fresh $100 million buyback program approved, running until Feb. 18, 2027. Eyes are on those timelines—and on how aggressively the company buys back stock—as the next potential trigger after Friday’s open.
